|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
289,870,000 |
Market
Cap: |
65.74(B) |
Last
Volume: |
1,691,719 |
Avg
Vol: |
1,407,619 |
52
Week Range: |
$225.07 - $283.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 224 |
Guru Rank Value : 5.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,597 |
9,836 |
17,573 |
47,101 |
Total Sell Value |
$2,028,812 |
$2,316,830 |
$4,382,400 |
$12,101,842 |
Total People Sold |
3 |
3 |
6 |
8 |
Total Sell Transactions |
4 |
5 |
10 |
16 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Campion Simon D |
EVP and Segment President |
|
2020-01-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(58) |
8,897 |
|
- |
|
Larson Betty D |
EVP HR & CHRO |
|
2020-01-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(374) |
8,305 |
|
- |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2020-01-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(213) |
12,144 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2020-01-02 |
4 |
AS |
$271.28 |
$9,051,257 |
D/D |
(33,365) |
208,864 |
|
-3% |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2020-01-02 |
4 |
D |
$271.28 |
$3,277,876 |
D/D |
(12,083) |
242,229 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2020-01-02 |
4 |
OE |
$72.12 |
$3,277,710 |
D/D |
45,448 |
254,312 |
|
- |
|
Ring Timothy M |
Director |
|
2020-01-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,027) |
74,278 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
186 |
208,864 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-12-16 |
4 |
AS |
$269.51 |
$3,196,389 |
D/D |
(11,860) |
9,811 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-12-16 |
4 |
D |
$269.51 |
$1,635,387 |
D/D |
(6,068) |
21,671 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2019-12-16 |
4 |
OE |
$134.73 |
$1,637,374 |
D/D |
12,153 |
27,739 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2019-12-16 |
4 |
S |
$269.63 |
$1,721,857 |
D/D |
(6,386) |
17,117 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2019-12-16 |
4 |
D |
$269.63 |
$2,027,887 |
D/D |
(7,521) |
21,549 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2019-12-16 |
4 |
OE |
$134.73 |
$2,027,590 |
D/D |
13,907 |
27,117 |
|
- |
|
Campion Simon D |
EVP and Segment President |
|
2019-12-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(133) |
8,955 |
|
- |
|
Spoerel Thomas J |
VP Controller & Chief Acct Off |
|
2019-12-13 |
4 |
S |
$267.95 |
$135,583 |
D/D |
(506) |
1,035 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-12-12 |
4 |
AS |
$265.57 |
$3,087,517 |
D/D |
(11,626) |
209,050 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-12-12 |
4 |
D |
$265.57 |
$1,252,694 |
D/D |
(4,717) |
220,676 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2019-12-12 |
4 |
OE |
$76.64 |
$1,252,528 |
D/D |
16,343 |
225,393 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-12-12 |
4 |
S |
$263.23 |
$89,235 |
D/D |
(339) |
15,310 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-12-12 |
4 |
D |
$263.23 |
$1,025,807 |
D/D |
(3,897) |
15,649 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-12-12 |
4 |
OE |
$242.10 |
$1,025,536 |
D/D |
4,236 |
19,546 |
|
- |
|
Campion Simon D |
EVP and Segment President |
|
2019-12-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(147) |
9,088 |
|
- |
|
Kaltenbach Patrick |
EVP & Pres Life Sciences |
|
2019-12-06 |
4 |
S |
$261.51 |
$81,591 |
D/D |
(312) |
15,310 |
|
- |
|
Campion Simon D |
EVP and Segment President |
|
2019-12-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
50 |
9,235 |
|
- |
|
863 Records found
|
|
Page 13 of 35 |
|
|